Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Vaccination Against Influenza in Patients With Scleroderma

NCT01002508 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT01002508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01002508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Vaccination Against Influenza in Patients With Scleroderma
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2009
Completion date
March 31, 2010
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza vaccine in scleroderma